Search results
... Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans...
The Woonsocket Call· 10 hours agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of subjects achieved PASI 90 after 16 weeks of treatment in psoriasis ...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 7 days agoThat’s when I knew it was time to see a doctor and get help. Learn More: What Is Psoriasis? My Early...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 6 days agoThere, Joel M. Gelfand, MD, professor of dermatology and epidemiology at the University of Pennsylvania in Philadelphia, presented results from the LITE...
Why Do I Have a Rash Between My Breasts?
Verywell Health via Yahoo News· 4 days agoA rash between the breasts can develop for a variety of reasons, including heat, infection, or other more serious conditions like cancer. Here’s what to...
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 5 days agoWe aim to bring this novel treatment option to patients in need as quickly as possible.” The company...
What Can Nail Changes Say About Our Health? Here's What To Know
IFLScience· 3 days agoClues about your health may be right at your fingertips.
Thick Toenails
Health via Yahoo News· 3 days agoFortunately, treatments can help improve symptoms. But, your exact treatment plan will depend on the severity of the condition. Prevention strategies can...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 hour ago- New study follows completion of first-in-human Phase 1b trial in atopic dermatitis patients, in which selectION observed safety and tolerability of si-544 in the treatment
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 17 hours agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 7 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...